SBP-101 (Spark Biopharma)

N/A

Report date: 2022/05/10 11:38:35

NME

Base Information

Drug NameSBP-101 (Spark Biopharma)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHigh Mobility Group Protein B1 modulators

TargetsHigh Mobility Group Protein B1

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSpark Biopharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

ATC CodeN/A